DM
ELVN icon

Deerfield Management’s Enliven Therapeutics ELVN Stock Holding History

Deerfield Management’s Portfolio ELVN Stock Details ELVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-19,866
Closed -$671K – 149
2021
Q1 		$671K Sell
19,866
-124,601
-86% -$6.33M 0.01% 131
2020
Q4 		$12.7M Buy
144,467
+15,054
+12% +$1.26M 0.25% 93
2020
Q3 		$10.5M Buy
129,413
+23,413
+22% +$2.11M 0.26% 81
2020
Q2 		$11.7M Sell
106,000
-19,000
-15% -$2.13M 0.34% 72
2020
Q1 		$8.02M Buy
+125,000
New +$7.96M 0.25% 74

Other funds holding ELVN

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return